Seven Percent of Outpatients Experience One or More Adverse Event
By Elana Gotkine HealthDay Reporter
MONDAY, May 6, 2024 -- Among outpatients, 7.0 percent have at least one adverse event (AE), with adverse drug events being the most common, according to a study published online May 7 in the Annals of Internal Medicine.
Noting that knowledge of outpatient AEs remains limited, David M. Levine, M.D., M.P.H., from Harvard Medical School in Boston, and colleagues describe the frequency and types of harm that occurred at 11 outpatient sites during one year. Data were reviewed for 3,103 patients who received outpatient care. Possible AEs were identified by nurse reviewers and adjudicated by physicians.
The researchers found that 7.0 percent of patients had at least one AE (8.6 events per 100 patients per year). The most common AEs were adverse drug events, health care-associated infections, and surgical or procedural events (63.8, 14.8, and 14.2 percent, respectively). AEs were never fatal; 17.4 and 2.1 percent were serious and life-threatening, respectively. Of the AEs, 23.2 percent were preventable. Having at least one AE occurred less often at ages 18 to 44 years versus ages 65 to 84 years (standardized risk difference, −0.05) and occurred more often with Black versus Asian race (standardized risk difference, 0.09). Overall, 1.8 to 23.6 percent of patients had at least one AE across study sites; there was considerable variation observed in the clinical category of AEs.
"We believe these data serve as an urgent call for patient safety research and innovation in the outpatient setting," the authors write.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted May 2024
Read this next
High Level of Approval Observed for Polygenic Embryo Screening
FRIDAY, May 17, 2024 -- There is a high level of approval for use of polygenic embryo screening, according to a study published online May 14 in JAMA Network Open. Rémy A...
AI Chatbots Can Generate Quality, Empathetic, Readable Responses
FRIDAY, May 17, 2024 -- For patient questions about cancer, artificial intelligence (AI) chatbots can generate quality, empathetic, and readable responses, according to a study...
Slight Decline Seen in U.S. Drug Overdose Deaths
THURSDAY, May 16, 2024 -- New 2023 provisional data from the National Center for Health Statistics show the first decline in deaths from drug overdose in the United States since...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.